BridgeMD
New treatment option for Arthroplasty Complications
Official title Are Elastic Restraints Still Necessary in Improved Rehabilitation Programs After Hip and Knee Prosthetic Surgery?
ClinicalTrials.gov ID: NCT06563531
What this study is testing
- What it's testing
- Venous thrombosis and pulmonary embolism are considered serious and potentially preventable complications of hip and knee replacement surgery. The risks of thrombosis must be weighed against the risks associated with preventive measures, both mechanical and pharmacological.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- first line and non-traumatic total hip or knee arthroplasty
- Patient included in an Enhanced Rehabilitation after Surgery (ERS) or "fast-track" protocol, or scheduled as an outpatient.
You likely can't join if
- Patient requiring long-term anticoagulation for pre-existing co-morbidity
- Patients with coagulation disorders (hypercoagulability)
- Patient undergoing thrombogenic pharmacological treatment
- History of obliterative arteriopathy of the lower limbs
- Arterial disease
- Obesity
See the full eligibility criteria
- first line and non-traumatic total hip or knee arthroplasty
- Patient included in an Enhanced Rehabilitation after Surgery (ERS) or "fast-track" protocol, or scheduled as an outpatient.
- Patient requiring long-term anticoagulation for pre-existing co-morbidity
- Patients with coagulation disorders (hypercoagulability)
- Patient undergoing thrombogenic pharmacological treatment
- History of obliterative arteriopathy of the lower limbs
- Arterial disease
- Obesity
- Heart failure
- Chronic bronchopneumopathy
- Lymphedema
- Chronic inflammatory disease
- Permanent wearing of elastic restraints
- Proximal or distal arterial bypass surgery
- Creatinine clearance \< 15 ml/min
- Inability to give consent
- Revision surgery for hip or knee prosthesis
- Metastatic cancer
- Life expectancy less than 3 months
- Allergy to socks or compression stockings
- Patients presenting one or more exclusion criteria for the fast-track protocol (severe or poorly-balanced associated conditions such as diabetes or immunodepression, inability to contact the doctor or hospital...
- Adults under guardianship or curatorship
- Vulnerable persons in accordance with article L1121-6 of the CSP (French Public Health Code)
The study team makes the final eligibility decision.
Where it's taking place
- Brest, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brest, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.